ARTICLE | Clinical News
Actimmune: Began Phase II trial
February 7, 2000 8:00 AM UTC
InterMune Pharmaceuticals Inc., Palo Alto, Calif. Product: Actimmune Business: Infectious diseases Therapeutic category: Bacterial infection, Immune modulation Target: Unknown Description: Interfero...